Timothy W Carte, MD in Polson, MT - Pediatrics

Timothy W Carte, MD is a Pediatrics physician based in Polson, Montana. Timothy W Carte is licensed to practice in Montana (license number 4409) and his current practice location is 6 13th Ave E, Polson, Montana. He can be reached at his office (for appointments etc.) via phone at (406) 883-5680.

NPI number for Timothy W Carte is 1770534315 and his current mailing address is 6 13th Ave E, Polson, Montana. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1770534315.

Contact Information

	Timothy W Carte, MD
	6 13th Ave E, Polson, MT 59860-5315
	(406) 883-5680
	(406) 883-8910

Physician's Profile

Full Name	Timothy W Carte
Gender	Male
Speciality	Pediatrics
Location	6 13th Ave E, Polson, Montana
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1770534315
Provider Enumeration Date: 05/16/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Timothy W Carte such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1770534315	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208000000X	Pediatrics	4409 (Montana)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Timothy W Carte is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Timothy W Carte, MD 6 13th Ave E, Polson, MT 59860-5315 Ph: (406) 883-5680	Timothy W Carte, MD 6 13th Ave E, Polson, MT 59860-5315 Ph: (406) 883-5680

News Archive

Thermo Fisher Scientific gets European Commission approval for Life Technologies deal

Thermo Fisher Scientific, the world leader in serving science, today announced that it has received approval from the European Commission for its pending acquisition of Life Technologies Corporation.

Study suggests unexpected role for NLRP3 protein in cancer vaccine development

The promise of vaccines targeted against various types of cancer has raised the hopes of patients and their families. The reality, however, is that these promising treatments are difficult to develop. One of the challenges is identifying a discrete cellular target to stop cancer growth without inactivating the immune system. Scientists at UNC Lineberger Comprehensive Cancer Center report a laboratory finding that has the potential to increase the effectiveness of therapeutic cancer vaccines.

CSL Behring donates protein therapies to World Federation of Hemophilia

In recognition of Rare Disease Day and as part of its ongoing commitment to the global bleeding disorders community, CSL Behring announced today that it is donating 2 million international units (IUs) of protein therapies to the World Federation of Hemophilia.

Novel motion capture-like technology for tracking how proteins fold into certain shape

In many modern animated movies, the trick to achieving realistic movements for individual characters and objects lies in motion-capture technology.

Timothy W Carte, MD - Pediatrics in Polson, MT